The 2020 NCCN Clinical Practice Guidelines for breast cancer incorporate novel systemic therapies, reflecting advancements in tumor biology. These updates enhance treatment paradigms for metastatic breast cancer, ultimately improving patient outcomes and survival rates through evidence-based recommendations. Personalized medicine approaches are increasingly emphasized.